Pharmaceuticals, Biotechnology and Life Sciences
Marks First Approval for KEYTRUDA in SCLC KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:MRK), known as MSD outside the United States and…
AstraZeneca and Merck’s LYNPARZA Reduced the Risk of Disease Progression or Death by 70% Compared to Placebo Following Response to…
LONDON–(BUSINESS WIRE)–#Biotechnology–According to Technavio Research Report “Global Chronic Renal Failure Therapeutics Market by product (antihypertensive therapeutics, antianemia therapeutics, and others)…
DUBLIN–(BUSINESS WIRE)–The “High Content Screening (HCS): Global Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The…
MHRA MIA (IMP) license enables international clinical trial manufacture and distribution EnteroBiotix meets with European Medicines Agency Innovation Task Force…
PORCHEVILLE, France–(BUSINESS WIRE)–A 34,000-square-metre science platform, SEQENS’Lab offers a unique ecosystem, dedicated to our customers to accelerate their projects from…
Agnès Pannier-Runacher, Secretary of State to the Minister of Economy and Finance to participate in the opening PORCHEVILLE, France–(BUSINESS WIRE)–Seqens,…
BioSerenity, developer of solutions dedicated to personalized patient continuous care, raises €65 million, including €50 million in Series B equity…
Novigenix SA, a leading Immuno-Transcriptomics company that develops and
commercializes products for early cancer detection and precision
medicine, today announced the appointment of Francois Martelet, M.D., to
its Board of Directors as a non-executive director. Dr. Martelet has
over 25 years’ experience at both corporate and operational level in
pharmaceutical and biotech companies.
Cannabis Industry in Lesotho, Africa to Become Gateway to EU Cannabis Markets Not for Distribution to U.S. Newswire Servicers or…